The Role of DNA Methylation in Placental Development and Preeclampsia
Author Information
Author(s): Yizi Meng, Yimei Meng, Linli Li, Yuan Li, Jin He, Yanhong Shan
Primary Institution: The First Hospital of Jilin University, Changchun, China
Hypothesis
This review aims to clarify the epigenetic processes essential for normal placental development and explore potential epigenetic biomarkers and therapeutic targets for preeclampsia.
Conclusion
DNA methylation plays a critical role in placental development and the pathogenesis of preeclampsia, with potential implications for diagnosis and treatment.
Supporting Evidence
- Preeclampsia affects approximately 3%–5% of pregnancies globally and is a leading cause of maternal and neonatal morbidity.
- DNA methylation is a key epigenetic modification that influences gene expression and is implicated in placental function.
- Altered DNA methylation patterns have been observed in placentas of preeclampsia patients, indicating its role in the disease's pathophysiology.
- Research suggests that understanding DNA methylation could lead to new diagnostic and therapeutic strategies for preeclampsia.
Takeaway
This study looks at how changes in DNA can affect the placenta and lead to pregnancy problems like preeclampsia, which can be dangerous for both moms and babies.
Methodology
This is a review article summarizing existing research on DNA methylation and its effects on placental development and preeclampsia.
Limitations
The review highlights the complexity of preeclampsia and the challenges in fully replicating its multifactorial nature in research models.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website